TM is the pioneer in developing specialized MR systems for dedicated markets. The Company has accumulated technologies to provide MR systems for niche market needs. The Company developed the world's first Neonatal superconducting MRI for baby and children and won the invention award "Geneva Award" of Geneva Invention Convention. The Neonatal MRI system is light, fast, accurate and safe, and is the best solution for neonatal imaging. Comparing to a conventional whole-body system, the Neonatal MR reduces the weight by 50%, the imaging time by 50%, the RF power deposition by 70%, and the noise by 75%!

The Company has developed an Abbreviated MRI (ABMR) for Breast imaging with AI reading. There are 8,600 breast mammography centers in the United States with annual screening rate of 80% women aged over 45. However, X-ray based mammography has radiation risk in addition to a lower accurate rate of 60%.  The Company plans to jointly set up independent breast imaging screening centers to provide safe and accurate diagnosis service for the increasing breast cancer annual screening need.